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Background: Follistatin (FST) has been shown to bind to some TGF-β family members and can function as a potent
myostatin (MSTN) antagonist. Recent studies have revealed that over-expression of FST by adeno-associated viruses
increases muscle growth in mice, humans and nonhuman primates. In the present study, to determine the effect of
FST on ovine primary myoblast (OPM) proliferation, FST was over-expressed using an adeno-associated virus
serotype 2 (AAV 2) vector.
Results: Western blot results showed that AAV induced the expression of FST protein in transduced OPM cells.
Real-time quantitative PCR results indicated that over-expression of FST resulted in a dramatic increase in Akt I and
CDK2 expression and a decrease in p21 expression. Moreover, cell cycle analysis confirmed that FST down-regulated
p21, a CDK inhibitor, and increased the level of CDK2 expression in OPM cells. Hence, follistatin positively regulated
the G1 to S progression. Our results showed that FST induced proliferation through a down-regulation of p21, as
only the p21 expression level was down-regulated as a result of FST over-expression in myoblasts, whereas no
change was observed in the level of p57 expression.
Conclusions: These results expanded our understanding of the regulation mechanism of FST in ovine primary
myoblasts. Our results provide the first evidence that the AAV viral system can be used for gene transfer in ovine
myoblast cells. Moreover, the results showed that an AAV vector can successfully induce the expression of FST in
OPM cells in vitro. These findings demonstrated that FST over-expression induces proliferation through a
down-regulation of the p21 gene under proliferating conditions.
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Currently, somatic cell nuclear transfer or pronuclear in-
jection is used to generate transgenic domestic animals.
These methods are inefficient, and in some species, they
are associated with a high risk of developmental abnormal-
ities in the resulting offspring [1]. Recently, virus-mediated
transfer has been employed to generate transgenic animal.
Viral vectors provide an alternative, efficient mechanism
of delivery. However, there is some controversy regarding
the efficiency of transmission of exogenous DNA by viral
vectors, such as retroviruses, adenoviruses and lentiviruses
[2]. In contrast to retroviruses, recombinant adenovirus-
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unless otherwise stated.dividing cells [3]. Adeno-associated viruses are small, non-
pathogenic, dependent parvoviruses that can integrate in a
site-specific manner into chromosomes [4,5]. The rAAV
genome can integrate into the host chromosome, facili-
tating long-term transduction [6]. Recombinant AAV
preparations are stable and can be produced at high titers
of more than 1012 particles per ml [7]. Adeno-associated
viral (AAV) vectors transduce a variety of somatic tissues,
including skeletal muscle, without eliciting an immune re-
sponse in mice [8]. Moreover, recent reports have indicated
that adeno-associated virusesare capable of integrating the
FST gene into the host chromosome and facilitating long-
term transduction [9,10]. Follistatin (FST) has been dem-
onstrated to be a potent antagonist of other members of
the TGF-β family, including myostatin [11]. In addition,
FST has been shown to be both safe and effective in mice
and in nonhuman primates [10]. Studies have also shown
that FST is capable of controlling muscle mass throughtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[12]. Myostatin (MSTN) negatively regulates myoblast
differentiation through activation of the Smad, Akt,
p38MAPK and p21 pathways [13-15]. Antagonists of
MSTN have shown considerable promise for enhancing
muscle mass and strength. MSTN inhibits proliferation
and differentiation of myoblasts, limiting the growth rate
and muscle mass in mammals [12,16]. Recent studies have
highlighted the potential benefit of inhibiting MSTN,
which results in a double muscle phenotype in MSTN-
deficient cattle [17] and MSTN-knockout mice [18]. In
particular, because sheep are an economically important
animal, breeding double muscle sheep is of high economic
value. However, AAV-mediated FST gene transfer has not
been reported in sheep, whereas there are several reports
of FST gene transfer in sheep by other vectors, such as
lentiviral vectors [19]. The objective of the current study
was to use a recombinant adeno-associated virus serotype
2 (rAAV2) carrying follistatin to explore the effects of FST
on ovine primary myoblast (OPM) proliferation in vitro.
In the present study, we tested the hypothesis that an
AAV virus carrying the FST gene is capable of inducing
myoblast proliferation in vitro. Additionally, because we
recognized that FST is expressed in OPM cells, we verified
whether over-expression of FST influences the prolifera-
tion of myoblasts irrespective of myostatin. Finally, RT-
qPCR analysis was carried out to detect the transcript
levels of FST, p21, CDK2, AkT I and ActRII B, which are
genes that are thought to play roles that are redundant
with MSTN for regulating muscle mass. Our results dem-
onstrated that the FST gene is capable of inducing the pro-
liferation of OPM in vitro. Moreover, the findings indicated
that in OPM, over-expression of FST induced proliferation
both directly or indirectly through down-regulation of the
p21 gene under proliferating conditions.
Results
Expression analysis of ovine follistatin and myostatin
To determine whether FST and MSTN mRNA are
expressed in OPM, total RNA and protein were isolated
from OPM cells and from ovine fetal skeletal muscle to
be used as a control and analyzed using RT-PCR. Agar-
ose gel electrophoresis confirmed the expression of FST
(Figure 1A) and MSTN mRNA (Figure 1B). The ovine
FST and MSTN appeared as a single band on 1.5% (w/v)
agarose gels. Electrophoresis of the PCR products
showed the 1144 and 151 bp fragments for FST and
MSTN, respectively. Next, western blot analyses were
performed on protein extracts to detect FST and MSTN
protein weight and their properties. Total protein was
extracted from OPM cells that were cultured in growth
media in 12-well plates for 72 h. The ovine FST protein
appeared as a single band with a molecular weight of
66 kDa in SDS–PAGE (Figure 1C). Moreover, anti-MSTN antibodies specifically recognized the two follow-
ing bands: precursor and processed forms of MSTN
(Figure 1D). These two bands corresponded to the
unprocessed full-length protein (52-kDa) and the mature
processed MSTN (26-kDa). However, this 52-kDa pre-
cursor myostatin was not detectable in muscle extracts.
These results indicated that OPM cells are capable of
synthesizing FST and MSTN mRNA and protein
in vitro.
To confirm the RT- qPCR results, FST and MSTN
protein expression were also measured by western blot
analysis for OPM cultured in GM over an 8-day time-
course proliferation. Western blot results indicated that
MSTN and FST protein expression was up-regulated
during proliferation. FST protein expression was de-
creased at day 8, whereas MSTN expression remained
constant at the end of culture period (Figure 1E).
Cloning of ovine follistatin
The full-length sequence of the gene encoding FST in
OPMs, containing a 1035 bp segment encoding the 344
amino acid, was cloned into a pGEM-T vector and se-
quenced (GenBank Accession No. KF833357). From the
follistatin CDS sequence, the amino acid sequence was
deduced using software from NCBI. Multiple alignments
of the amino acid sequences were produced via DNA-
MAN 6.0, as shown in Figure 2A. The deduced amino
acid sequence of the ovine FST is highly homologous
to amino acid sequences of follistatins from ovine
(Ovisaries, NP_001244022.1, 100%), goat (caprahircus,
ADJ53355.1, 99%), bovine (Bos Taurus, NP_786995.2,
99%) and human (Homo sapiens, NP_037541.1, 92%)
ovaries.
Follistatin protein is synthesized in transduced myoblast
cells
Construction of the expression vector is shown in Figure 2B.
FST cDNA was subcloned into pAAV-IRES-GFP, resulting
in the recombinant expression plasmid pAAV-CFS-FLAG
(Figure 2B), which was verified via DNA sequencing. Our
results confirmed the expression of ovine FST in the trans-
duced OPM cells. As shown in Figure 2C, anti-flag mono-
clonal antibodies specifically recognized a 66-kDa band for
ovine FST in the transduced OPMs. The result here for
recombinant FST driven by CMV promoter in transduced
cells was similar with observed band in Figure 1C for
endogenous FST.
Changes in mRNA concentration during myoblast
proliferation
To characterize the growth rate of the OPM cells, the
cells were seeded at 2 × 104 cells/well in 6-well plates
and harvested and counted for eight days. The result
indicated that the cells entered the logarithmic phase of
Figure 1 Detection of follistatin and myostatin mRNA and protein in ovine primary myoblast cells. A, determination of follistatin mRNA
and myostatin. B, mRNA expression by RT-PCR in primary muscle myoblasts and ovine fetal skeletal muscle, as a control. M is 100 bp DNA ladder
marker. C, detection of ovine follistatin protein in primary myoblasts via western blot analysis. 15 μg of total protein was resolved by 12% SDS-PAGE.
Polyclonal anti-follistatin (Santa Cruz) was the primary antibody used in the western blot. D, detection of myostatin protein in ovine primary myoblast
cells and ovine fetal skeletal muscle extracts by western blot analysis. Twenty micrograms of total protein from ovine fetal muscle and 60-day-old ovine
primary myoblasts was resolved by 10% SDS-PAGE, and myostatin protein was detected with rabbit anti-myostatin antibodies. Precursor and processed
forms of myostatin are indicated. Molecular masses of the western positive bands are indicated. E, Densitometry analysis of protein expression for
western blots (myostatin and follistatin) was normalized to GAPDH expression in ovine primary myoblast cells over a time-course of 8 days.
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Figure 2 Box shade diagram showing similarity of deduced amino acid sequences encoding ovine follistatin in primary myoblast cells.
A, Multiple sequence alignment of proteins was carried out using the DNAMAN 6.0 method based on amino acid sequences of follistatins from
Ovisaries (NP_001244022.1), Bos Taurus (NP_786995.2), Capra hircus (ADJ53355.1) and Homo sapiens (BC004107.2). B, Gene map of recombinant
plasmid pAAV-CFS-FLAG: ITR: inverted terminal repeat; CMV promoter: Cytomegalovirus promoter; FST: coding region for follistatin; IRES: internal
ribosome entry site; GFP: green fluorescent protein; hGHpA: human growth hormone (hGH) polyA signal; C, Detection of FST-FLAG proteins in
transduced and normal ovine primary myoblasts by western blot analysis. 15 mg of total protein was resolved by 12% SDS-PAGE. Monoclonal
anti-Flag (Sigma) were the primary antibody used in the western blot.
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Some fused cells were observed after 6 days. Eight days
after incubation, many of the cells were fused and had a
long tubular shape (data not shown). Next, to gain insight
into the role of follistatin during OPM proliferation and to
assess the expression of p21, p57, Act RIIB, Akt I, CDK2,
MSTN and FST genes during OPM proliferation, total
RNA was isolated from the OPM cells and harvested atdays 2, 4, 6 and 8. In addition, the cells were harvested at
day 1 to be used as a control. Then, the mRNA concentra-
tion was quantified by RT-qPCR. We noted that there
were no significant changes in Act RIIB mRNA expression
(Figure 3F). As shown in Figure 3, FST, MSTN, Akt I and
CDK2 mRNA concentrations were up-regulated during
OPM proliferation. The amounts of these genes gradually
increased at day 2 (P <0.01) after plating and then sharply
Figure 3 Real time quantitative PCR results of p21 (A), FST (B), CDK2 (C), MSTN (D), Akt I (E), ActRIIB (F)and p57 (G) mRNA expression
during proliferation of ovine primary myoblast. Cells cultured in 6-well plates for eight days and harvested at days 2, 4, 6 and 8. The mRNA
concentrations were quantified by real-time quantitative PCR. The amount of mRNAs was normalized to the amount GAPDH mRNA. Data were
analyzed by one-way ANOVA (P < 0.05, n = 8). Statistical differences are indicated: a > b > c > d.
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declined at day 8 (P <0.01) after plating, whereas the level
of MSTN mRNA remained constant until the end of the
culture period. As shown in Figure 3, the maximum ex-
pression levels of FST and CDK2 were observed at day 6.
Both genes began to show increased expression after
2 days, reaching a maximum expression at day 6, and
exhibited low expression at day 8. Moreover, the results
showed that the p21 and p57 mRNA concentrations weredown-regulated during myoblast proliferation (Figure 3A).
Interestingly, the minimum expression levels of p21 and
p57 were observed at day 6 (Figure 3A). However, the
levels of p21 and p57 mRNA were both increased at day
8, which paralleled the increase in MSTN mRNA concen-
tration and the reduction in FST mRNA concentration at
day 8. Taken together, these findings strengthened the
hypothesis that FST may be involved in the proliferation
of myoblasts.
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In this experiment, total RNA was extracted from the
transduced OPM to detect p21, p57, Myo D, Akt I,
CDK2 and Myf5 gene expression using RT-qPCR under
proliferating conditions. We noted that AAV-CFs-FLAG
exhibited a 12.5-fold reduction in p21 mRNA expression
(P < 0.01). Moreover, the expression of CDK2 exhibited a
6.1-fold increase (P < 0.01) compared to the control. In
addition, Akt I mRNA expression exhibited a dramatic
41-fold increase (P < 0.01).These data also revealed that
the expression of Myf5 mRNA exhibited a 2.5-fold de-
crease (P < 0.01). In addition, there were no significant
changes in Myo D and p57 mRNA concentrations com-
pared to the control (Figure 4).
Follistatin over-expression increases proliferation of ovine
primary myoblasts
To determine the effect of ovine FST protein on OPM
cell proliferation, we cultured OPM cells for 48, 72 and
96 h in growth media infected with or without the
AAV-CFs-FLAG virus. The cells were fixed and stained
with Giemsa (Figure 5A, a–f ). OPM proliferation was
monitored for alterations using a WST-8 assay with Cell-
Counting Kit-8 (CCK-8) reagents. As shown in Figure 5B,
the optical density (at 450 nm) was significantly increased
in the transduced OPMs cultured in GM media after 48,
72 and 96 h compared with the control, indicating that
FST significantly increased proliferation (P< 0.01). How-
ever, the FST protein induced the growth of myoblasts in
a time-dependent manner with half-maximal induction
occurring at the 72 h time point (Figure 5B). In addition,
FST did not cause an increase in myotube formation andFigure 4 Real time quantitative PCR results of p21, MyoD, Akt I, CDK2
myoblasts cultured under proliferating conditions. Total RNA was isola
non-transduced OPMs (control). Gene expression was determined using re
myoblasts and AAV-GFP were selected as the control and negative controlovert differentiation (Figures 5A, a–f ).These data indi-
cated that when OPM cells were incubated in GM with
the AAV-CFs-FLAG virus for 96 h, there was a steady in-
crease in cell number compared to the control (Figure 5A,
a–f ). The results strongly suggested that AAV-CFs-FLAG-
expressing FST induced a significant effect on cell myoblast
proliferation, suggesting that it is involved in modulating
myoblast proliferation.
FST protein interferes at the G1 phase of the cell cycle
The cell cycle was analyzed using a fluorescence-activated
cell sorter (FACS) after staining with propidium iodide
(Figure 6). The cells were transduced in growth medium
for 72 and 96 h. The percentage of cells in the G1, S, and
G2/M phases was significantly different under the various
conditions (P< 0.05). The detailed values of the cell cycle
analysis are summarized in Table 1. As shown in Table 1,
the percentage of cells in G1 was significantly decreased
and the percentage in S phase increased with AAV-CFs-
FLAG transduction. The FACS analysis also showed a
dramatic increase in the number of cells in S phase
(9.23 ± 1.60% to 27.10 ± 1.81%), which was accompanied
by a decrease in the percentage of cells in G1 (85.45 ±
2.12% to 63.43 ± 1.95%) phase of the cell cycle (Figure 6;
Table 1). In addition, there were no significant changes
in AAV-GFP during the G1 and S phases compared to
non-transduced cells (Figure 6B). Furthermore, AAV-
CFs-FLAG transduction reduced the G1 phase in a
time-dependent manner, with the maximum reduction
at 96 h post-infection (Figure 6D). These data suggest
that follistatin reduced the G1 phase in growth medium.
The results confirmed that the increase in myoblast, p57 and Myf5 genes expression in transduced primary
ted after 96 h from the OPM transduced with AAV-CFS-FLAG and the
al-time qPCR and normalized to GAPDH mRNA. The non-transduced
, respectively. **, P < 0.01 with non-transduced control.
Figure 5 Induction of ovine primary myoblast proliferation by AAV-CFs-FLAG virus expressing FST protein in vitro. A, phase contrast
pictures show the morphology of ovine primary myoblast cells after follistatin over-expression, as compared to negative control cells. After
Giemsa staining, pictures were taken under the same magnification over a time-course of 4 days. Myoblasts were grown for 48, 72 and 96 h in
growth media without or with AAV-CFs-FLAG virus transduction. Cells were fixed and stained with Giemsa. Bar =100 μM. B, absorbance (at 450 nm)
was read at 48, 72 and 96 hours after plating in growth media without or with AAV-CFs-FLAG virus. Data were analyzed by one-way
ANOVA (**P <0.01, n = 8).
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cells in G1 phase (Figure 6; Table 1).
Discussion
Recent studies have shown that human myoblast prolif-
eration is induced by an over-expression of FST in cell
culture. In addition, FST forms a complex with MSTN,
preventing its interaction with its receptor and thus
blocking the MSTN signal [20]. In the present study,ovine FST was cloned into the AAV2 vector, and then
AAV2 virus particles of high titer were obtained. The
OPM cells were infected by recombinant AAV vectors.
After total RNA and protein isolation, real-time qPCR
and western blotting were performed for the OPMs cul-
tured in the GM. Furthermore, a cell proliferation assay
was performed using Cell-Counting Kit-8 (CCK-8) re-
agents. The cells were stained with propidium iodide
and were analyzed using a flow cytometer for cell cycle
Figure 6 Effect of follistatin over-expression on ovine primary myoblast cell cycle progression. A, cell cycle distribution was measured by
flow cytometry using propidium iodide stain and the percent of the cell cycle phase is shown in a bar graph form with the G1 (85.45%) and S
(9.23%) phases. B, cell cycle distribution was measured by flow cytometry and the percent of the cell cycle phase is shown in a bar graph form
with the G1 (81.65%) and S (11.49%) phases. C, cell cycle distribution was measured by flow cytometry using propidium iodide stain and the
percent of the cell cycle phase is shown with the G1 (73.93%), and S (16.24%). D, cell cycle distribution was measured by flow cytometry and the
percent of the cell cycle phase is shown with the G1 (63.43%), and S (27.10%).
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acid sequence deduced from the cloned full-length DNA
sequence of FST contained an N-terminal domain (resi-
dues 1 ~ 63), domain 1 (64 ~ 136), domain 2 (137 ~ 211),
domain 3 (212 ~ 288), and a C-terminal region (288 ~ 315).
Therefore, the sequence indeed encoded the longest
form of FST [21]. The western blot analyses showed that
the ovine FST protein appeared as a single band with a
molecular weight of 66-kDa in SDS–PAGE (Figure 2B),
consistent with previous studies [19]. In this study, we
observed the precursor and the processed MSTN at 52
and 26-kDa proteins, respectively (Figure 2F). These
observations were consistent with previous reports
[16,22-24]. These results indicated that the MSTN
protein was indeed synthesized and proteolytically
processed in the OPMs.
To understand the regulation mechanism of MSTN
and FST protein and their interaction, real-time qPCR
analysis was performed on the OPM cells undergoingTable 1 The percentage of cells in G1, G2/M and S-phases un
Conditions G1 (%)
Non-transduced control (after 96 h) 85.45 ± 2.1
96 hours Post-Infection with AAV-GFP 81.65 ± 2.4
72 hours Post-Infection with AAV-CFs-FLAG 73.93 ± 1.8
96 hours Post-Infection with AAV-CFs-FLAG 63.43 ± 1.9
Cell cycle analysis was performed at 72 and 96 hours after those cells was transduc
were determined. The percentage of cells in G1 phase was greatly significant 96 ho
Statistical differences are indicated: a > b > c.proliferation. Moreover, to confirm the RT- qPCR results,
FST and MSTN protein expression were also measured by
western blot analysis. FST and MSTN mRNA concentra-
tions were up-regulated at mRNA (Figure 3B and D) and
protein level (Figure 1E), whereas p21 and p57 mRNA
concentrations were down-regulated during OPM prolif-
eration (Figure 3A and G). Despite the increased expres-
sion of MSTN mRNA, p21 and p57 mRNA expression
was decreased in this condition. It has been thought that
increased expression of MSTN leads to an up-regulation
of p21 and p57 mRNA expression [23]. The lack of
consistency demonstrated that the FST protein, as a bind-
ing protein for MSTN, may prevent MSTN from binding
to receptors on the myoblast cells and thus block the
MSTN signal [20]. However, the RT-qPCR results showed
that FST over-expression only down-regulated p21 mRNA
expression and had no effect on p57 mRNA expression.
These results confirmed that FST induces proliferation
through a down-regulation of p21 because only p21 levelsder different conditions (mean ± S.E.M)
G2 /M (%) S (%)
2a 5.32 ± 0.87b 9.23 ± 1.60c
1a 6.86 ± 1.12ab 11.49 ± 1.34c
5b 9.83 ± 0.56a 16.24 ± 1.45b
5c 9.47 ± 0.93a 27.10 ± 1.81a
ed with AAV-CFs-FLAG and the percentage of cells in G1, G2/M and S-phase
urs AAV post-infection. Data were analyzed via one-way ANOVA (P < 0.05).
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myoblasts (Figure 4), whereas no change was observed in
the level of p57 expression [23].
Because FST can lead to increased muscle mass [9], it is
possible that FST functions by increasing the number of
myoblasts during development. To examine this possibil-
ity, we incubated myoblast cultures with an AAV vector
carrying the FST gene. The results indicate that FST in-
deed induces the proliferation of exponentially growing
myoblasts (Figure 5A). Moreover, because the surviving
myoblasts at the end of the assay reflect the net result of
cell proliferation, we performed a flow cytometry analysis
to assess the cell cycle progression in the transduced myo-
blasts. The flow cytometry analysis showed that when
myoblasts were transduced with the AAV-CFS-FLAG
virus, a decreased number of myoblast cells was arrested
inG1phase, and therefore, more myoblast cells made the
transition to S (DNA synthesis) phase (Figure 6; Table 1).
Consistent with this finding, others have suggested that
MSTN can inhibit myoblast proliferation [23,25,26]. In-
vestigations into the mechanisms revealed that one of the
targets of MSTN signaling is the cell cycle. In cell culture
studies, MSTN inhibited the progression of myoblasts at
the G1 phase of the cell cycle. This cell cycle arrest was
shown to be mediated by p21, which was the only CDK
inhibitor to be up-regulated by MSTN. In addition, myos-
tatin treatment also specifically reduced the levels of
CDK2, the combination of which resulted in markedly re-
duced activity of CDK2. This, in turn, led to the hypopho-
sphorylation of retinoblastoma protein and thus inhibited
the progression of cells into the S phase of the cell cycle
[23]. Here, in the OPMs infected with AAV-CFs-FLAG,
there was indeed a decrease in p21 expression at the
transcription level and an increase in CDK2 expression
(Figure 4) under proliferating conditions, which led to a
decrease in the arrest of myoblasts in the G1-phase of the
cell cycle. FST likely forms a complex with MSTN, pre-
venting its interaction with its receptor and thus blocking
the MSTN signal [20]. Thus, the observed increase in the
number of myoblast cells is the result of deregulated
(increased) myoblast proliferation. These observations are
consistent with the model proposed by Thomas et al. [23]
regarding the role of MSTN during muscle growth [23].
We propose the following model for the role of FST in
myoblast proliferation regulation. In response to MSTN
signaling, consistent with the up-regulation of p21, CDK2
expression is down-regulated, which causes the hypopho-
sphorylation of the Rb protein and G1 arrest. Therefore,
these results confirmed the role of FST in myoblast prolif-
eration regulation.
Conclusions
Our results provide the first evidence that an AAV viral
system can be used for gene transfer in sheep. Moreover,the results showed that an AAV vector can successfully
induce expression of FST in OPM cells in vitro. In
addition, our findings demonstrated that FST induces
proliferation through a down-regulation of the p21 gene
under proliferating conditions in ovine primary myoblasts.
In the future, it would be interesting to determine whether




DNA was purified and manipulated, as described pre-
viously [27].
Chemicals, strains, plasmids and media
T4 deoxyribonucleic acid (DNA) ligase and restriction
endonucleases were purchased from New England Biolabs
(Beverly, MA) and Fermentase (Life Sciences, Thermo
Fisher), respectively. Escherichia coli DH5 alpha (Invitrogen,
CA, USA) was used as a host for the plasmid cloning
experiments. Bacteria were grown in Luria-Bertani (LB)
medium containing 5 g/L yeast extract, 10 g/L tryptone
and 10 g/L NaCl at pH = 7.0 and 37°C. The pAAV-IRES-
GFP plasmids, consisting of a CMV promoter and a
FLAG tag, the pAAV-GFP control, and the pAAV-RC and
pHelper vectors were purchased from Agilent Technolo-
gies Company (La Jolla, CA). The pGM-T plasmid vector
for the direct insertion of a blunt PCR product into a plas-
mid vector was obtained from Invitrogen Company (CA,
USA). Plasmids were amplified in DH5 alpha bacteria,
purified (Gene JET Plasmid Maxiprep Kit; Fermentas, Life
Sciences, Thermo Fisher) and dissolved in nuclease-free
water. Dulbecco’s Modified Eagle’s Medium (DMEM) was
supplemented with 100 U/ml penicillin and 100 μg/ml
streptomycin. Fetal bovine serum (Hyclone, Logan, UT)
and horse serum (Hyclone, Logan, UT) were also added
to DMEM to prepare specific media.
Cloning of the full-length follistatin sequence
Ovine full-length FST cDNA was isolated from a primary
myoblast cDNA library, and its sequence was determined.
To detect the full-length FST cDNA sequence, the total
RNA was extracted from OPMs using a GeneJET RNA
Purification Kit (Fermentas, Life Sciences, Thermo Fisher).
Then, the cDNA was synthesized using a Maxima First
Strand cDNA Synthesis Kit (Fermentas, Life Sciences,
Thermo Fisher) according to the manufacturer’s proto-
col. The DNA encoding FST was amplified via PCR
from cDNA using the forward primer 5′-GCACCG
CTTGCCAGAGCCAC -3′ and the reverse primer 5′-
GGTGGAGGGTTTACCACTCTAGAATGGA -3′, which
were designed based on the availability of bovine se-
quences (Gen Bank Accession No. NM_175801). The
PCR reaction was carried out in a final volume of 20 μl
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available PCR master mix (PyroStart™ Fast PCR Master
Mix (2×), Fermentas, Life Sciences, Thermo Fisher).
After brief centrifugation, the PCR amplification was
carried out in an ABI 9700 PCR system (Applied Biosys-
tems, Foster City, CA, USA). The conditions for the
PCR amplification were as follows: initial denaturation
was performed at 94°C for 4 min, followed by 35 cycles
at 95°C for 30 s, 60°C annealing for 30 s, and 72°C
extension for 1 min, and a final extension at 72°C for
10 min. The amplified DNA was ligated into a pGM-T
vector and transformed into DH5a (E. coli). The DNA
sequence was determined after digestion by a restriction
enzyme, electrophoresis, and sequencing. The amino
acid sequence of the cloned DNA sequence was deter-
mined using software from NCBI. Multiple alignments
of the amino acid sequence were produced using DNA-
MAN 6.0.
Construction of the pAAV-CFS-FLAG plasmid vector
A complete open reading frame (ORF) of 1035 base pairs
of the ovine FST gene was amplified via PCR from full-
length cDNA using the forward primer 5′-AAGAA
TTCCCTCAGGATGGCCCGTCCTA-3′ (P1) contain-
ing an EcoRI site (bold) and the reverse primer 5′-
GCTCGAGGGTTTTCCACTCTAGAATGGA -3′ (P2)
containing an XhoI site (bold). The primers were de-
signed based on the availability of ovine sequences
(Gene Bank Accession No. KF833357). The PCR reac-
tions and conditions were carried out as described
above. The PCR products and the pAAV-IRES-GFP vec-
tor (Agilent Technologies Company, La Jolla, CA) were
digested with EcoRI and XhoI (Fermentas, Life Sciences,
Thermo Fisher), recovered through agarose gel electro-
phoresis, and then ligated by T4 DNA ligase (New England
Biolabs, Beverly, MA). New recombinant plasmids, which
consisted of a CMV promoter and a FLAG tag, carrying
the ovine FST gene were termed pAAV-CFS-FLAG. The
ligated plasmid vector was transformed into E. coli DH5
alpha. A single colony of the transformed bacteria was
selected and transferred to 3 ml of Luria-Bertani (LB)
medium containing 100 μg/mL ampicillin and incubated
overnight under vigorous shaking (200 rpm) at 37°C. The
culture was used to extract the recombined plasmid. The
presence of the FST protein was confirmed via digestion
with a restriction enzyme, electrophoresis, and sequencing.
Packaging AAV vectors
AAV particles were produced by co-transfection of the
recombinant pAAV-CFS-FLAG vector (20 μg) with two
helper plasmids (20 μg each of pAAV-RC and pHelper)
into HEK 293 cells seeded in a 225-cm2 flask. Briefly,
1 h before transfection, half of the medium was replaced
with fresh medium, and 20 μg of vector and of eachhelper plasmid was added to 4 ml of 300 mM CaCl2.
This solution was added to 4 ml of 2× HBS and mixed
immediately by gently inverting three times. The mix-
ture was immediately pipetted into HEK 293 cells in
40 ml of DMEM medium with 10% FCS. The plate was
incubated at 37°C for 6 h. Three days after transfection,
1 ml of 0.5 M EDTA was add and incubated for 3 min at
room temperature. The supernatant was collected at 24,
48, and 72 h via centrifugation at 1000 × g for 10 min at
4°C. Next, the supernatant was removed and the cells of
the pellet were resuspended in 2 ml of TBS. The cells
were freeze-thawed that had been suspended in TBS
three times by placing them alternately in a dry ice/etha-
nol bath until the suspension was completely frozen and
in a water bath of 37°C until it was completely thawed.
Then, the tissue debris was removed via centrifugation
at 20,000 g for 10 min, and the supernatant was col-
lected. The collected supernatant was filtered through a
0.45-μm low protein binding filter (Millipore, Billerica,
MA, USA). Finally, a ViraBind™ Adeno-Associated Virus
Purification Mega Kit (Cell Biolabs, INC, San Diego, CA,
USA) was used according to manufacturer’s protocol. The
titer of the virus concentrate was determined by transdu-
cing 293 cells with serial dilutions. The suspended virus
particles were diluted using serial dilutions of 10−1, 10−2,
10−3, and 10−4. After culturing for 48 h, the titers were
determined by counting the number of GFP-positive
colonies using a fluorescence microscope. The titers
were expressed as transducing units/mL (TU/mL). The
virus preparation used for transgenesis had a final titer
of greater than 1012 transducing units/mL.
Ovine primary myoblast culture
Primary myoblast cultures were obtained from 60-day-old
sheep fetuses, as previously described [28]. Briefly, hind
limb skeletal muscle mass was excised, cut into small
pieces, placed in DMEM containing 20% FBS and 10%
Me2SO, and frozen in liquid nitrogen for subsequent
myoblast cultures. Primary muscle cultures were grown
in growth media (DMEM with 10% FBS, 100 U/mL
penicillin and 100 μg/mL streptomycin) in 6-cm petri
dishes to test for fibroblast contamination. Preliminary
studies (data not shown) indicated that approximately
90% of the ovine primary myoblast cells stained positive
for the muscle-specific marker desmin. All studies were
approved by the Biological Studies Animal Care and
Use Committee, Beijing, Peoples Republic of China.
Transduction of primary myoblast cells
For transduction of primary myoblasts with AAV-CFs-
FLAG or AAV-GFP control vectors, a ViraDuctin™ AAV
Transduction Kit (Cell Biolabs, INC, San Diego, CA,
USA) was used according to the manufacturer’s instruc-
tions as the transduction reagent. Briefly, the OPM cells
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AAV virus with the optimal multiplicity of infection
(MOI) of 50 was added to the fresh growth medium.
The cells were incubated at 37°C for 6 h. Finally, pre-
warmed complete medium was added in each well and
incubated at 37°C for 48, 72 or 96 h. The green fluores-
cence excited by the AAV vector was observed using a
fluorescence microscope (ECLIPSE TE2000-U, Nikon,
Tokyo, Japan) at 48, 72 or 96 h.RNA isolation and RT-PCR
The total RNA was isolated from primary myoblast cells
and ovine fetal skeletal muscle (20 mg) using a Thermo
Scientific GeneJET RNA Purification Kit (Fermentas,
Life Sciences, Thermo Fisher) according to the manufac-
turer’s instructions. The quality of RNA was verified using
a spectrophotometer (Astra Gene, Astra net, Cambridge,
USA) at 260/280 nm (OD260/OD280 = 1.8–2.0). The
cDNA was prepared from 1 μg of total RNA using a
Maxima First Strand cDNA Synthesis Kit (Fermentas,
Life Sciences, Thermo Fisher) according to the manu-
facturer’s protocol. The sequences of primers, amplicon
size and annealing temperature are shown in Table 2.
The PCR reactions and conditions were carried out as
described above.Table 2 Primers used for RT-PCR and real time quantitative P
Gene Primer sequence (5′–3′) Anne
Myostatin F: 5′-CTGGCCCAGTGGATCTGAATGAG −3′ 60
R: 5′- TTCCAGGCGAAGCTTACTGAGGA-3′
Follistatin F: 5′-TGGACCGAGGAGGACGTGAA-3′ 60
R: 5′-AGACGCAGCGGGGTTTGTTC-3′
ActRIIB F: 5′-TCCCTCACGGATTACCTCAAG-3′ 58
R: 5′-TCCCTGTGGGCAATAGATGG-3′
Myf5 F: 5′-ACCAGCCCCACCTCAAGTTG-3′ 60
R: 5′-GCAATCCAAGCTGGATAAGGAG-3′
MyoD F: 5′-CGACTCGGACGCTTCCAGT-3′ 60
R: 5′-GATGCTGGACAGGCAGTCGA-3′
P21 F: 5′-GCAGACCAGCATGACAGATTT-3′ 58
R: 5′-GGATTAGGGCTTCCTCTTGGA-3′
P57 F: 5′- CGCCGCACCTTTCCCATG-3′ 59
R: 5′- CCCGCAGTGGCATGTCCA-3′
CDK2 F: 5′-CATGGATGCCTCTGCACTCACTG-3′ 60
R: 5′-AGGACCCGATGAGAGTGGCAGAA-3′
Akt1 F: 5′-CAGCATCGTGTGGCAGGAC-3′ 60
R: 5′-TCTTGGTCAGGTGGCGTAA-3′
GAPDH F: 5′-CAAGTTCCACGGCACAGTCA-3′ 60
R: 5′-TGGTTCACGCCCATCACAA-3′Real-time quantitative RCR analysis
Myoblast cells (3.0 × 103 cells/well) were cultured in GM
in 48-well plates. Total RNA was isolated after 96 h
from the OPM transduced with AAV-CFS-FLAG and
the non-transduced OPMs (control). Moreover, an AAV-
GFP control vector was also selected as a negative con-
trol for these experiments. The mRNA concentrations
for all of the genes, which are listed in Table 2, were
quantified via real-time quantitative PCR (RT-qPCR).
Primer sequences were designed using the Vector NTI
Advance™ 11. The sequences of primers for PCR amplifi-
cation are shown in Table 2. In this procedure, GAPDH
was used as a house-keeping gene for normalizing the
gene expression data of the RT-qPCR. RT-qPCR was
performed using a BIO-RAD iQ5 Real-time PCR Detec-
tion System (Bio-Rad, Hercules, CA, USA) with a Power
SYBR-Green PCR Master Mix Kit (Applied Biosystems,
Foster City, CA, USA). RT-qPCR was carried out with a
final volume of 20 μL containing 1 μL RT product,
10 μL SYBR-Green PCR master mix (2×), 2.5 μM for-
ward and reverse primers and nuclease-free water. The
PCR cycling programs were as follows: 3 min of UNG
incubation at 55°C, followed by 10 min at 95°C, 40 cycles
at 95°C for 10 s, annealing at an optimized annealing
temperature for 15 s (temperatures given in Table 2), ex-
tension at 72°C for 15 s, plate-reading every 0.2°C fromCR
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final extension step of 72°C for 10 min. Finally, fluores-
cence data were analyzed using the iQ5 Optical System
Software (Bio-Rad). Gene expression was normalized to
GAPDH expression using the 2–ΔΔC T method [29].
Western blot analysis
Total protein was extracted from the normal myoblast
cells and the transduced myoblast cells to determine
MSTN and FST protein expression. Total protein was
obtained from hind limb fetal skeletal muscle as a control.
Protein concentrations were determined according to the
manufacturer’s instructions (Bio-Rad, Hercules, CA, USA).
A total of 15 μg protein was separated via SDS-PAGE
(12%) and transferred to a nitrocellulose membrane via
electro-blotting. SDS-PAGE and western blot transfer were
performed using standard techniques. The gels run under
non-reducing conditions. The following primary antibodies
were used in this study: MSTN, goat polyclonal anti-
MSTN antibody (sc-6884, 1:500; Santa Cruz); FST-FLAG,
mouse monoclonal anti-FLAG M2 antibody (F-3165; 1:500;
Sigma); FST, rabbit polyclonal anti-FST antibody (sc-30194,
1:500; Santa Cruz) and GAPDH, mouse monoclonal anti-
GAPDH antibody (G8795, 1:5000; Sigma). HRP-conjugated
goat anti-mouse IgG antibody (115-035-174, 1:10,000;
Jackson Immuno Research, West Grove, PA, USA), rabbit
anti-goat IgG-HRP (sc-2922, 1:5000; Santa Cruz) and
HRP-conjugated goat anti-rabbit IgG antibody (111-
035-003, 1:10,000; Jackson Immuno Research) were
used as secondary antibodies.
For myostatin protein detection, protein (20 μg) was
loaded for electrophoresis on a 10% gel and transferred to
nitrocellulose membrane (Millipore, Billerica, MA, USA)
by wetting transferring. Membranes were stained with
Ponceau stain to verify loading. Membranes were blocked
in 3% BSA-TBST and incubated overnight at 4°C with
primary antibodies. Then, Membranes washed five times
for 5 min each time with TBST, and incubated for 60 min
at room temperature with secondary antibodies.
For GAPDH-loading controls, the membrane was
blocked in 3% BSA-TBST and incubated with anti-GAPDH
antibody in 3% vBSA-TBST for 3 h at room temperature,
followed by incubation with secondary antibody in
TBST +5% milk for 60 min at room temperature. Horse-
radish peroxidase activity was detected using ECL with
western blotting reagents (RPN2132, Amersham Biosci-
ences). Finally, the protein expression quantified by densi-
tometry by the Gel Quant NET software, and normalized
to GAPDH.
Proliferation assay
The OPM cells were grown prior to the assays in growth
media. Cell proliferation assays were conducted in 48-well
plates. After a 16-h attachment period, the cells weretransduced with the AAV-CFs-FLAG vector. The plates
were then incubated at 37°C and 5% CO2 for48, 72 and
96 h. After the incubation period, the cell proliferation
assay was performed by adding 20 μl of the Cell-Counting
Kit-8 (CCK-8) reagents (Dojindo Molecular Technologies,
Maryland, USA) to each well of the plate for 2 h. Finally,
the absorbance at 450 nm was measured using a Spectra
Max M5 microplate reader (Molecular Devices, CA,
USA).
Cell cycle analysis
The cell cycle analysis was performed with cells seeded
in 48-well plates (3 × 103 cells/well) in growth media.
The cells were allowed to attach overnight. The cultures
were transduced with the AAV-CFs-FLAG vector and
incubated for 72 and 96 h. The collected cells were then
washed in PBS and fixed in 75% ethanol. The cells were
stained with 50 μg/mL propidium iodide containing
10 μg/mL RNase A and then analyzed in a FACS Calibur
flow cytometer (BD Biosciences, CA, USA). The per-
centages of cells in the G1, S, and G2-M phases were
determined.
Statistical analysis
The data are expressed as the mean ± SEM. The results
were analyzed via one-way analysis of variance (ANOVA)
(general linear model) using SPSS software (version 13.0).
The positions of the samples on the plate were randomly
assigned, and all samples were run in replicates of eight.
Significant differences between treatments were tested
using a Student’s t- test. Differences are reported at two
significance levels, 0.05 or 0.01.
Availability of supporting data
The mRNA-seq data were deposited at NCBI with the Gen
Bank accession number KF833357 (http://www.ncbi.nlm.
nih.gov/nuccore/KF833357).
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